NSC |
Compound |
Enrichment |
Correlation |
NSC 731409 |
Null |
0.00206000157707806 |
0.13142313 |
NSC 666870 |
Null |
0.00209154338952974 |
0.045078626 |
NSC 690778 |
Null |
0.00227699677919298 |
-0.057145459 |
NSC 737672 |
9-Acetamido-6-(3-bromopropyl)-5,6-dihydro-3-nitro-5,11-dioxo -11H-indeno[1,2-c]isoquinoline |
0.00227699677919298 |
0.22836292 |
NSC 76919 |
2-Pyridinecarboxylic acid, 5-amino-6-(7-amino-1,2,3,4,5,8-hexahydro- 5,8-dioxo-2-quinolinyl)-4-(2-hydroxy- 3,4-dimethoxyphenyl)-3-methyl- |
0.00227699677919298 |
0.11989043 |
NSC 740973 |
6-(3-Azidopropyl)-5,6-dihydro-9-methoxycarbonyl-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.00272369215216526 |
0.43583649 |
NSC 610457 |
Camptothecin Derivative |
0.0027236921521653 |
0.050388616 |
NSC 734982 |
Ethyl 4-[6-(2-furyl)-2-(methylsulfanyl)-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate |
0.00336064452966828 |
0.5657348 |
NSC 644945 |
Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6-one, 5,5a,6,8,8a,9-hexahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)- 9-[2-(dimethylamino)ethoxy]-, stereoisomer, hydrochloride |
0.00356914129105574 |
0.12151651 |
NSC 678473 |
Null |
0.00356914129105574 |
0.19774507 |